Cormorant CEO Chen Reveals a Large MLTX Buy

JC Parets
March 23, 2023

The largest insider buy on today’s list comes in a Form 4 filing by Bihua Chen, the CEO of Cormorant Asset Management.

Chen revealed a purchase of $16.7 million in MoonLake Immunotherapeutics $MLTX.

Western Standard LLC revealed a purchase of $1,849,996 in Merrimack Pharmaceuticals $MACk.

Here’s The Hot List, with data through March 22, 2023:

In another Form 4, director Thurman J. Rodgers disclosed the acquisition of 102,599 shares of Enovix Corporation $ENVX.

There was also insider activity in OneWater Marine $ONEW, SecureWorks Corp, $SCWX and Pebblebrook Hotel Trust $PEB.

Stay tuned. We'll be back on Friday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under: